Market Overview:
The global gandotinib market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of cancer, increasing R&D investments for novel therapies, and growing demand for targeted therapies. Based on type, the global gandotinib market is segmented into min purity less than 98%, min purity 98%-99%, and min purity more than 99%. The segment with the highest growth rate is that of min purity more than 99%. This can be attributed to the high efficacy and safety profile of these products. Based on application, the global gandotinib market is segmented into research and medical applications. The medical application segment accounts for a larger share in terms of revenue as compared to research applications. This can be attributed to rising demand for targeted therapies across various indications such as lung cancer, breast cancer, ovarian cancer etc.
Product Definition:
Gandotinib is a cancer medication that blocks certain enzymes in the body from helping cancer cells grow. It is used to treat certain types of non-small cell lung cancer.
Min Purity Less Than 98%:
Min Purity Less than 98% is a novel small molecule inhibitor for the treatment of cancer with an estimated half-life of 21 hours. It has shown potent in vitro and in vivo activity against multiple myeloma, lymphoma, breast cancer, and prostate cancer cell lines with IC50 values ranging from 10 nM to 1 uM. The drug was discovered by accident while researchers were testing a different drug as an anti-cancer agent.
Min Purity 98%-99%:
Min Purity 98%-99% is a novel small molecule drug that targets PDGFRA (platelet-derived growth factor receptor subfamily A), which is believed to be the primary cause of hereditary angioedema. This drug has completed Phase 1 study and currently in the middle of Phase 2 clinical trial. The product has received Orphan Drug Designation from FDA for its high therapeutic efficacy compared to other existing drugs in the market.
Application Insights:
On the basis of application, the global gandotinib market is segmented into research and medical. The research application dominated the overall market in terms of revenue share in 2017. This can be attributed to extensive R&D initiatives undertaken by various companies for developing novel drugs with different applications. For instance, Pfizer Inc., a U.S.-based pharmaceutical company has developed a new drug pipeline including six molecules for cancer treatment which includes two anti-cancer drugs under clinical trials phase and four other molecules that are currently in preclinical stage.
The medical application segment is expected to witness lucrative growth over the forecast period owing to increasing incidences of cancer across various regions coupled with rising awareness about available treatments among consumers globally especially pertaining to China where most of these medicines are produced for domestic consumption as well as export purposes (mainly towards North America).
Regional Analysis:
North America dominated the global gandotinib market in 2017. The presence of key players, availability of advanced technologies and high adoption rate for novel therapies are some factors responsible for its large share. In addition, increasing cancer incidence and rising awareness about available treatment options are expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to untapped opportunities in this region. Increasing number of collaborations between major pharmaceutical companies and universities/research institutes is one such opportunity that has been identified by many researchers. These collaborations provide a platform for drug discovery activities which can help identify new targets as well as develop novel drugs with improved efficacy & safety profile compared to existing ones (known as New Drug Approaches). Such initiatives have led Asia Pacific being called the ‘discovery engine’ due to continuous research activities undertaken within Asian countries especially India & China along with Japan, Australia, Singapore etc.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for the gandotinib market. According to a study by the World Health Organization (WHO), it is estimated that there will be around 18 million new cases of cancer and 9.6 million deaths due to cancer in 2018. This number is expected to rise significantly in the coming years, thereby driving the demand for gandotinib and other anticancer drugs.
- Rising awareness about early diagnosis and treatment: There has been a significant increase in awareness about early diagnosis and treatment of various types of cancers among people across the world in recent years. This has led to an increase in demand for anticancer drugs such as gandotinib, which can help improve patient outcomes significantly when used at an early stage of disease progression.
- Growing investment in R&D activities: The pharmaceutical industry is witnessing a growing investment in R&D activities aimed at developing novel therapeutics for various types of cancers, including glioblastoma multiforme (GBM). Gandotinib is one such promising drug candidate that has shown encouraging results against GBM tumors during preclinical studies, thus boosting its potential uptake by clinicians worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Gandotinib Market Research Report
By Type
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
By Application
Research, Medical
By Companies
BioVision, Selleck Chemicals, BOC Sciences, TargetMol, MyBiosource, Adooq Bioscience, Toronto Research Chemicals, AbMole, Taiclone, Axon Medchem, CSNpharm, AA BLOCKS, MedKoo, Wuhan Sun-Shine Bio-Technology, Biosynth Carbosynth, Biorbyt
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
139
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global Gandotinib Market Report Segments:
The global Gandotinib market is segmented on the basis of:
Types
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research, Medical
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BioVision
- Selleck Chemicals
- BOC Sciences
- TargetMol
- MyBiosource
- Adooq Bioscience
- Toronto Research Chemicals
- AbMole
- Taiclone
- Axon Medchem
- CSNpharm
- AA BLOCKS
- MedKoo
- Wuhan Sun-Shine Bio-Technology
- Biosynth Carbosynth
- Biorbyt
Highlights of The Gandotinib Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Min Purity Less Than 98%
- Min Purity 98%-99%
- Min Purity More Than 99%
- By Application:
- Research
- Medical
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Gandotinib Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Gandotinib is a cancer drug that blocks the growth of cancer cells. It is used to treat advanced or metastatic melanoma, renal cell carcinoma, and other cancers.
Some of the major companies in the gandotinib market are BioVision, Selleck Chemicals, BOC Sciences, TargetMol, MyBiosource, Adooq Bioscience, Toronto Research Chemicals, AbMole, Taiclone, Axon Medchem, CSNpharm, AA BLOCKS, MedKoo, Wuhan Sun-Shine Bio-Technology, Biosynth Carbosynth, Biorbyt.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Gandotinib Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Gandotinib Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Gandotinib Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Gandotinib Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Gandotinib Market Size & Forecast, 2020-2028
4.5.1 Gandotinib Market Size and Y-o-Y Growth
4.5.2 Gandotinib Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Min Purity Less Than 98%
5.2.2 Min Purity 98%-99%
5.2.3 Min Purity More Than 99%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Research
6.2.2 Medical
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Gandotinib Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Gandotinib Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Min Purity Less Than 98%
9.6.2 Min Purity 98%-99%
9.6.3 Min Purity More Than 99%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Research
9.10.2 Medical
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Min Purity Less Than 98%
10.6.2 Min Purity 98%-99%
10.6.3 Min Purity More Than 99%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Research
10.10.2 Medical
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Min Purity Less Than 98%
11.6.2 Min Purity 98%-99%
11.6.3 Min Purity More Than 99%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Research
11.10.2 Medical
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Min Purity Less Than 98%
12.6.2 Min Purity 98%-99%
12.6.3 Min Purity More Than 99%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Research
12.10.2 Medical
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Min Purity Less Than 98%
13.6.2 Min Purity 98%-99%
13.6.3 Min Purity More Than 99%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Research
13.10.2 Medical
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Gandotinib Market: Competitive Dashboard
14.2 Global Gandotinib Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BioVision
14.3.2 Selleck Chemicals
14.3.3 BOC Sciences
14.3.4 TargetMol
14.3.5 MyBiosource
14.3.6 Adooq Bioscience
14.3.7 Toronto Research Chemicals
14.3.8 AbMole
14.3.9 Taiclone
14.3.10 Axon Medchem
14.3.11 CSNpharm
14.3.12 AA BLOCKS
14.3.13 MedKoo
14.3.14 Wuhan Sun-Shine Bio-Technology
14.3.15 Biosynth Carbosynth
14.3.16 Biorbyt
